Suppr超能文献

基于阻抗与双水平压力的自动调压持续气道正压通气治疗难治性睡眠呼吸暂停综合征:一项前瞻性随机交叉研究

Auto-adjusting CPAP based on impedance versus bilevel pressure in difficult-to-treat sleep apnea syndrome: a prospective randomized crossover study.

作者信息

Randerath Winfried J, Galetke Wolfgang, Ruhle Karl-Heinz

机构信息

Department for Pneumology, Allergology and Sleep Medicine, University Witten/Herdecke, Germany.

出版信息

Med Sci Monit. 2003 Aug;9(8):CR353-8.

Abstract

BACKGROUND

Although continuous positive airway pressure therapy (CPAP) is the treatment of choice for obstructive sleep apnoea syndrome (OSAS), there is a portion of patients in which CPAP is not usable. Bilevel treatment serves as an alternative for these patients. For uncomplicated OSAS, auto-adjusting CPAP based on the forced oscillation technique (APAPFOT) has proved to be equally as effective as constant CPAP, and is preferred by the patients. The aim of this study was to investigate the question whether, in the event of primary CPAP intolerance, high pressures (>or =12 cm H2O) or SAS with > or =10% central respiratory disorders, APAPFOT is as effective as bilevel therapy in reducing respiratory disturbances.

MATERIAL/METHODS: 27 patients (23 m, 4 f, age 57.2+/-13.1 years, BMI 33.5+/-7.8 kg/m2) were treated with bilevel and APAPFOT for 6 weeks each in a prospective randomized cross-over study. The efficacy of the treatment modes was examined polysomnographically.

RESULTS

Both modalities significantly improved the respiratory disturbances (AHI: baseline 49+/-27.3/h, bilevel 9.8+/-12.5, p<0.01, APAPFOT 13.8+/-13.2, p<0.01) and sleep quality (arousals: baseline 43+/-28.3/h, bilevel 17.7+/-8.8, p<0.01, APAPFOT 20.5+/-10.7, p<0.01), with no significant differences between the modalities. Under APAPFOT, mean treatment pressure was substantially reduced (bilevel 8.3+/-2.5, APAPFOT 5.1+/-1.7, p<0.01). The majority of patients gave preference to APAPFOT for long-term treatment (21 vs. 6 patients, p<0.05).

CONCLUSIONS

In patients with difficult-to-treat OSAS, APAPFOT has proved to be just as effective as bilevel therapy, but has the advantage of meeting with greater acceptance.

摘要

背景

尽管持续气道正压通气治疗(CPAP)是阻塞性睡眠呼吸暂停综合征(OSAS)的首选治疗方法,但仍有一部分患者无法使用CPAP。双水平治疗可作为这些患者的替代方案。对于单纯性OSAS,基于强迫振荡技术的自动调压CPAP(APAPFOT)已被证明与持续CPAP同样有效,且更受患者青睐。本研究的目的是探讨在原发性CPAP不耐受、高压(≥12 cm H2O)或中枢性呼吸紊乱≥10%的SAS情况下,APAPFOT在减少呼吸紊乱方面是否与双水平治疗同样有效。

材料/方法:在一项前瞻性随机交叉研究中,27例患者(23例男性,4例女性,年龄57.2±13.1岁,体重指数33.5±7.8 kg/m2)分别接受双水平治疗和APAPFOT治疗,各为期6周。通过多导睡眠图检查治疗模式的疗效。

结果

两种治疗方式均显著改善了呼吸紊乱(呼吸暂停低通气指数:基线时49±27.3次/小时,双水平治疗后9.8±12.5次/小时,p<0.01;APAPFOT治疗后13.8±13.2次/小时,p<0.01)和睡眠质量(觉醒:基线时43±28.3次/小时,双水平治疗后17.7±8.8次/小时,p<0.01;APAPFOT治疗后20.5±10.7次/小时,p<0.01),两种治疗方式之间无显著差异。在APAPFOT治疗下,平均治疗压力显著降低(双水平治疗为8.3±2.5,APAPFOT为5.1±1.7,p<0.01)。大多数患者更倾向于长期使用APAPFOT治疗(21例对6例,p<0.05)。

结论

在难治性OSAS患者中,APAPFOT已被证明与双水平治疗同样有效,但具有更易被接受的优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验